These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12668872)
1. A novel and functional interaction between cyclophilin A and prolactin receptor. Syed F; Rycyzyn MA; Westgate L; Clevenger CV Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain. Kline JB; Rycyzyn MA; Clevenger CV Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696 [TBL] [Abstract][Full Text] [Related]
3. N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting. Buteau H; Pezet A; Ferrag F; Perrot-Applanat M; Kelly PA; Edery M Mol Endocrinol; 1998 Apr; 12(4):544-55. PubMed ID: 9544990 [TBL] [Abstract][Full Text] [Related]
4. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. Dif F; Saunier E; Demeneix B; Kelly PA; Edery M Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228 [TBL] [Abstract][Full Text] [Related]
5. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531 [TBL] [Abstract][Full Text] [Related]
6. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element. Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725 [TBL] [Abstract][Full Text] [Related]
7. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor. Miller SL; DeMaria JE; Freier DO; Riegel AM; Clevenger CV Mol Endocrinol; 2005 Apr; 19(4):939-49. PubMed ID: 15618286 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the intermediate isoform of the human prolactin receptor. Kline JB; Roehrs H; Clevenger CV J Biol Chem; 1999 Dec; 274(50):35461-8. PubMed ID: 10585417 [TBL] [Abstract][Full Text] [Related]
9. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Perrot-Applanat M; Gualillo O; Pezet A; Vincent V; Edery M; Kelly PA Mol Endocrinol; 1997 Jul; 11(8):1020-32. PubMed ID: 9212050 [TBL] [Abstract][Full Text] [Related]
10. New mechanisms for PRLr action in breast cancer. Clevenger CV; Gadd SL; Zheng J Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262 [TBL] [Abstract][Full Text] [Related]
11. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Rycyzyn MA; Reilly SC; O'Malley K; Clevenger CV Mol Endocrinol; 2000 Aug; 14(8):1175-86. PubMed ID: 10935542 [TBL] [Abstract][Full Text] [Related]
12. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Lebrun JJ; Ali S; Goffin V; Ullrich A; Kelly PA Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4031-5. PubMed ID: 7537382 [TBL] [Abstract][Full Text] [Related]
13. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. Lebrun JJ; Ali S; Ullrich A; Kelly PA J Biol Chem; 1995 May; 270(18):10664-70. PubMed ID: 7537736 [TBL] [Abstract][Full Text] [Related]
14. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site. Kline JB; Moore DJ; Clevenger CV Mol Endocrinol; 2001 May; 15(5):832-41. PubMed ID: 11328862 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of c-Src by prolactin is independent of Jak2. Fresno Vara JA; Carretero MV; Gerónimo H; Ballmer-Hofer K; Martín-Pérez J Biochem J; 2000 Jan; 345 Pt 1(Pt 1):17-24. PubMed ID: 10600634 [TBL] [Abstract][Full Text] [Related]
16. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras. Chang WP; Ye Y; Clevenger CV Mol Cell Biol; 1998 Feb; 18(2):896-905. PubMed ID: 9447986 [TBL] [Abstract][Full Text] [Related]
17. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
18. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015 [TBL] [Abstract][Full Text] [Related]
19. The role of prolactin receptor in GH signaling in breast cancer cells. Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981 [TBL] [Abstract][Full Text] [Related]
20. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Gadd SL; Clevenger CV Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]